PledPharma – pharmaceutical daily

January 17, 2019 Off

PledPharma to present its Phase III program for PledOx at CI Cancers Syposium

PledPharma will present its “first in class” drug candidate PledOx phase III program at the Gastrointestinal (GI) Cancers Symposium, taking place in San Francisco today and tomorrow.

December 24, 2018 Off

PledPharma seeks to cut costs for Aladote, expects orphan drug designation

By Dino Mustafić

PledPharma has filed an application for an Orphan Drug Designation (ODD) to the US FDA for the its drug candidate which should reduce liver injury by paracetamol overdose, Aladote.

January 19, 2017 Off

PledPharma’s Nomination Committee wants board changes

By Dino Mustafić

PledPharma’s Nomination Committee has submitted a proposal for a new composition of the Board of Directors for consideration at an…